Malwa Marathon to be held in Indore on December 18
Indore, Nov 24 (UiTV/IANS) - Ultra runner Sameer Singh will be the star attraction in the Malwa Marathon to be held in Indore on December 18. Expressing his excitement about…
Apple makes Rs 1.5L each seconds, Microsoft Rs 1.1L
New Delhi, Nov 24 (UiTV/IANS) - Do you know how much profit Apple makes every second? It is a staggering over $1,820 (over Rs 1.48 lakh), making the iPhone maker…
‘Tu Saamne Aaye’ is a peppy number with good use of colours and landscape
Mumbai, Nov 24 (UiTV/IANS) - Sri Lankan singer Yohani's first Hindi single 'Tu Saamne Aaye' hit the airwaves on Thursday. The song also features his 'Manike' co-singer Jubin Nautiyal. The…
Tesla Full Self-Driving beta now available: Elon Musk
San Francisco, Nov 24 (UiTV/IANS) - Elon Musk on Thursday said that the Tesla Full Self-Driving (FSD) beta is now available to anyone in North America. "Tesla Full Self-Driving Beta…
Dubai port fire: Court upholds verdict against Indian, 4 others
Dubai, Nov 24 (UiTV/IANS) - The Court of Appeals in Dubai has upheld a verdict against five men, including an Indian, who were convicted of causing massive fire and blast…
Microsoft adds ‘Portrait mode’ feature to PowerPoint for iPhones
San Francisco, Nov 24 (UiTV/IANS) - Microsoft has added a new feature -- 'Portrait mode' in PowerPoint for iPhones and iPad users so that they can easily switch between portrait…
Karnataka govt assures all help to incense industry
Bengaluru, Nov 24 (UiTV/IANS) - Karnataka government is ready to extend all the cooperation for the incense industry, said Chief Minister Basavaraj Bommai. Speaking after inaugurating AIAMA-2022 organised by All…
YouTube starts beta testing quiz feature for community posts
San Francisco, Nov 24 (UiTV/IANS) - YouTube has started testing a new feature which will allow creators to add quizzes to their community posts. The new feature is in beta…
Omicron Subvariant Resistant to All Antibody Therapies: Scientist
New Delhi, Nov 24 (UiTV/IANS) - Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all approved antibody therapies, a new Lancet study led by an Indian-origin researcher…
